Table 2 Serum level of FT3 and clinical characteristics in AIS patients
Clinical features | FT3 (pmol/L) | p value |
|---|---|---|
TIA history | ||
 Yes | 4.62 ± 0.79 | NS |
 No | 4.27 ± 0.67 | |
Recurrence | ||
 Yes | 4.68 ± 0.51 | NS |
 No | 4.47 ± 0.67 | |
Hypertension | ||
 Yes | 4.43 ± 0.62 | NS |
 No | 4.67 ± 0.48 | |
Diabetes | ||
 Yes | 4.84 ± 0.51 | NS |
 No | 4.43 ± 0.62 | |
Hyperlipidemia | ||
 Yes | 4.65 ± 0.42 | NS |
 No | 4.57 ± 0.38 | |
Hyperhomocysteinemia | ||
 Yes (>15 μmol/L) | 4.54 ± 0.63 | NS |
 No (≤15 μmol/L) | 4.73 ± 0.53 | |
Smoking (n) | ||
 Yes | 4.74 ± 0.57 | NS |
 No | 4.48 ± 0.55 | |
Drinking (n) | ||
 Yes | 4.93 ± 0.41 | NS |
 No | 4.42 ± 0.54 | |
Atrial fibrillation | ||
 Yes | 4.98 ± 0.43 | NS |
 No | 4.63 ± 0.53 | |
Stroke history | ||
 Yes | 4.86 ± 0.41 | NS |
 No | 4.56 ± 0.51 | |
with periventricular WMH | ||
 Grade 1 | 4.43 ± 0.57 | NS |
 Grade 2 | 4.17 ± 0.52 | |
 Grade 3 | 4.15 ± 0.49 | |
with subcortical WMH | ||
 Grade 1 | 4.45 ± 0.54 | NS |
 Grade 2 | 4.21 ± 0.46 | |
 Grade 3 | 4.13 ± 0.0.56 | |
with lacunes | ||
 Yes | 4.24 ± 0.55 | NS |
 No | 4.66 ± 0.62 | |
NIHSS on admission | ||
  > 3 | 4.11 ± 0.52 | 0.013 |
  ≤ 3 | 4.87 ± 0.24 | |
mRS (3 mos) | ||
  > 2 | 4.17 ± 0.35 | 0.002 |
  ≤ 2 | 4.97 ± 0.32 | |